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Abstract: Intervertebral disc herniation may contribute to inflammatory processes that associate with radicular pain and 
motor deficits. Molecular changes at the affected dorsal root ganglion (DRG), spinal cord, and even midbrain, have been 
documented in rat models of radiculopathy or nerve injury. The objective of this study was to evaluate gait and the 
expression of key pain receptors in the midbrain in a rodent model of radiculopathy. Radiculopathy was induced by 
harvesting tail nucleus pulposus (NP) and placing upon the right L5 DRG in rats (NP-treated, n=12). Tail NP was 
discarded in sham-operated animals (n=12). Mechanical allodynia, weight-bearing, and gait were evaluated in all animals 
over time. At 1 and 4 weeks after surgery, astrocyte and microglial activation was tested in DRG sections. Midbrain 
sections were similarly evaluated for immunoreactivity to serotonin (5HT2B), mu-opioid (μ-OR), and metabotropic 
glutamate (mGluR4 and 5) receptor antibodies. NP-treated animals placed less weight on the affected limb 1 week after 
surgery and experienced mechanical hypersensitivity over the duration of the study. Astroctye activation was observed at 
DRGs only at 4 weeks after surgery. Findings for pain receptors in the midbrain of NP-treated rats included an increased 
expression of 5HT2B at 1, but not 4 weeks; increased expression of μ-OR and mGluR5 at 1 and 4 weeks (periaqueductal 
gray region only); and no changes in expression of mGluR4 at any point in this study. These observations provide support 
for the hypothesis that the midbrain responds to DRG injury with a transient change in receptors regulating pain 
responses. 
Keywords: Dorsal root ganglion, gait, intervertebral disc, lumbar radiculopathy, metabotropic glutamate receptor, midbrain, 
mu-opioid receptor, serotonin receptor. 
INTRODUCTION 
 Herniation of the intervertebral disc (IVD) is a common 
cause of low back pain and may be associated with nerve 
root dysfunction, known as radiculopathy. Features of 
radiculopathy can range from radiating neuropathic pain to 
paresthesias and sensory deficits to motor deficits, and the 
societal cost of this pathology involves over 660,000 hospital 
visits and over 325,000 surgeries for discectomy procedures 
annually in the USA [1]. The consequent mechanical 
compression and biochemical irritation of nearby neural 
structures seems to be mediated by heightened inflammatory 
and immune cytokine expression alongside inflammatory 
cell infiltration [2-7]. Indeed, upon systemic exposure, the 
nucleus pulposus (NP) component of IVD tissue initiates a 
specific immune response, likely a consequence of its 
immune privileged avascular location bounded by the anulus 
fibrosus (AF) [8, 9]. 
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 There is clear interest in identifying the cell populations 
affected by disc herniation-induced radiculopathy, and the 
role of neurotransmitters and their receptors that mediate the 
symptomatic and functional deficits of radiculopathy. 
Animal models based on compression injury of the dorsal 
root ganglion (DRG) demonstrate resultant allodynia and 
functional deficits in association with an elevated microglial 
activation in the spinal cord [10-14]. In addition, molecular 
and mRNA changes occur locally at the DRG or in the spinal 
cord implicating key inflammatory mediators (e.g., TNF-, 
IL-1, nitric oxide) and neuropeptides (e.g., substance P) 
following DRG compression injury or exposure to autologus 
NP [9, 15-23]. These observations suggest a hypothesis that 
neuroplastic remodeling of the spinal cord can contribute to 
or modulate the pain and symptoms of disc herniation-
associated radiculopathy. 
 The goal of the current study was to expand the scope of 
the disc herniation associated radiculopathy model to 
understand not only the induced pain phenotype, but also the 
mechanisms underlying spontaneous functional recovery. In 
prior studies of a model of non-compressive disc herniation 
with autologous NP material, animals exhibited behavioral 
changes including heightened behavioral mechanical 
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sensitivity, stance symmetry, and gait parameters including 
symmetry and force analysis. Divergent findings of gait 
symmetry andmechanical sensitivity suggested supraspinal 
modulation of the nociceptive phenotype and promoted 
investigation into mechanisms underlying that descending 
control. An important objective of the current study was to 
evaluate a role for modified neurotransmitter receptor 
expression in the central nervous system at the midbrain to 
test if neuroplastic remodeling can occur central subsequent 
to DRG injury or sensitization. Thus, transient changes were 
studied here in a rodent model of non-compressive disc 
herniation. Immunohistochemical markers of 
neuroinflammation at the DRG and the presence of a 
monocyte chemotactic protein (MCP-1) were quantified in 
the cerebrospinal fluid. The expression of serotonin, 
metabotropic glutamate, and mu-opioid receptors was 
characterized in the periaqueductal gray and red nucleus 
regions of the midbrain by immunohistochemistry. 
MATERIALS AND METHODOLOGY 
Animal Model 
 Male Sprague-Dawley rats (n=30, 9 months old) were 
divided into sham (n=12), NP-treated (n=12), and pre-
operative control (n=6) groups. The sham and NP-treated 
groups underwent a previously described operation [15] as 
approved by Duke University Institutional Animal Care and 
Use Committee (IACUC) while the pre-operative control 
animals served as non-surgical control tissue. 
 In brief, under pentobarbital anesthesia, rats underwent 
surgical exposure of proximal tail IVD in which a single disc 
was punctured, the NP was harvested via curette, and the tail 
was closed. In these same animals, a dorsal exposure of the 
right L5 DRG was accomplished by a partial unilateral 
laminotomy and medial facetectomy, with autologous NP 
either discarded (sham) or placed onto the exposed DRG 
(NP-treated). Two-layer closure was performed and animals 
were returned to solitary cage housing for 5–7 days, 
followed by group housing until sacrifice. 
 Animals in sham and NP-treated groups were studied 
longitudinally for gait, stance symmetry, and behavioral 
sensitivity at pre-operative and post-operative time points. 
Animals were then sacrificed at 7 or 28 days post surgery 
(n=6 per animal group for each time point) after which the 
cerebrospinal fluid, midbrain and DRG were harvested. The 
pre-operative control animals were procured and midbrain 
harvested only to serve as a control group. 
Geometric and Temporal Gait Descriptors 
 To assess rodent gait, rat ambulation was recorded while 
freely exploring a custom-built gait arena (5’6” x 1’6”) pre-
operatively and at 1 and 4 weeks after surgery, as previously 
described [15]. When a rat passed through the middle of the 
arena, a high-speed video camera was manually triggered to 
capture the rat’s movement (Phantom V4.2, 200 frames per 
second; Vision Research, Wayne, NJ). Trials that contained 
a minimum of two complete gait cycles and a consistent 
velocity were saved for processing (5 trials per animal). 
Using custom code (DLTdataviewer), the video frame of 
foot-strike and toe-off events were determined viaby-hand 
digitization [24, 25]. Using these data, percentage stance 
time imbalance and gait symmetry were calculated for each 
trial. Percentage stance time (also known as limb duty factor) 
is the percentage of time a limb is in stance for a given 
stride, or mathematically as stance time divided by stride 
time [26]. Gait symmetry is the offset between left and right 
foot-strikes in a limb pair for a given stride, or 
mathematically as the time between left and right foot-strikes 
divided by time between two left foot-strikes [26]. Rats 
commonly ambulate with balanced, symmetric gaits, 
represented mathematically by a difference between the left 
and right percentage stance times of 0 and a gait symmetry 
of approximately 0.5; a shift in these variables would 
indicate an unbalanced or asymmetric gait, respectively. 
Data for each group (sham, NP-treated) were compared to 
the mathematical definitions for balanced, symmetric gait 
using a repeated measures t-test on time with a Bonferroni 
correction; differences amongst treatment groups and 
between pre-operative and post-operative timepoints were 
analyzed using a two-way ANOVA with a post-hoc Tukey’s 
test. 
Weight Distribution 
 Hind limb weight distribution was determined 
preoperatively and at 1 and 4 weeks after surgery. An 
incapacitance meter (IITC, Inc.) was used to measure weight 
distribution on the left and right limb, and data was acquired 
during 5 second intervals (5 trials per rat). Weight 
distribution for each group was compared to the 
mathematical definitions for balanced weight distribution 
using a repeated measures t-test on time with a post-hoc 
Bonferroni correction (unbalanced distribution  50% weight 
on right limb); differences amongst groups (sham, NP-
treated) and between pre-operative and post-operative 
timepoints were analyzed using a two-way ANOVA. 
Mechanical Sensitivity 
 Mechanical paw withdrawal thresholds were determined 
preoperatively and at 1 and 4 weeks after surgery using an 
up-down protocol described by Chaplan and coworkers [27]. 
Briefly, rats were placed in a wire-bottom cage and von Frey 
filaments (Stoelting) were applied to the plantar surface of 
rat’s hind paws. If paw withdrawal was observed, the next 
smallest filament was applied; if paw withdrawal was not 
observed, the next largest filament was applied. Using this 
up-down protocol, the 50% paw withdrawal threshold can be 
approximated; this threshold represents the mechanical force 
where paw withdrawal and stimulus tolerance are equally 
likely. A two-factor ANOVA followed by a post-hoc 
Tukey’s test was used to compare differences amongst 
treatment groups (sham, NP treated) and between pre-
operative and post-operative timepoints for the affected limb. 
DRG Immunostaining 
 At the time of dissection, lumbar DRGs from sham and 
NP-treated groups were dissected en bloc and placed in 
optical cutting temperature (OCT) embedding media (Sakura 
Finetek, Torrence CA) and frozen in liquid nitrogen until 
sectioning. Cryosections of DRG (7μm) were 
immunostained for glial fibrilary acidic protein (GFAP) to 
identify astrocytes. DRG sections were fixed in cold acetone 
(10 min, -20
o
C), permeabilized with 0.02% Triton-100, and 
incubated with blocking serum (30 min, 3.75% BSA (Gibco) 
and 5% goat serum (Zymed, Invitrogen, Carlsbad, CA)) to 
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minimize non-specific antibody binding. Sections were 
incubated with primary monoclonal mouse GFAP antibody 
(GFAP, SC-51908, Santa Cruz Biotechnology, Santa Cruz, 
CA) diluted 50x in blocking serum (2 hours at room 
temperature), washed with PBS and incubated with Alexa 
Fluor 488-conjugated secondary antibodies (30 min at 200x 
dilution in blocking serum, Molecular Probes, Invitrogen). 
 Separate DRG sections were immunostained to detect the 
presence of ionized calcium binding adaptor molecule 1 
(Iba1) to determine presence of macrophages. DRG 
cryosections were fixed in cold methanol and acetone 
mixture (1:1) for 5 min ( -20C), permeabilized with 0.5% 
Triton-100 (15 min, room temperature) and incubated with 
blocking serum (30 min, 1% BSA, 0.25% Triton-100, & 5% 
goat serum). Sections were incubated with rabbit polyclonal 
Iba1 antibody (Wako, 019-19741) with a 250x dilution in 
blocking serum overnight. DRG sections were washed with 
PBS and incubated with Alexa Fluor 488-conjugated 
secondary antibodies (30 min at 200x dilution in blocking 
serum, Molecular Probes). 
 All stained DRG sections were counterstained with 0.5 
mg/ml propidium iodide (Sigma-Aldrich) at room 
temperature for 15 minutes to stain the cell nuclei and 
mounted with GVA mounting medium (Zymed, Invitrogen). 
 Stained tissue sections were imaged using a confocal 
laser scanning microscope (Zeiss LSM 510, 20x objective; 
Zeiss, Jena, Germany) with 20x magnification. Multiple 
digital images (526x526) were acquired for each DRG 
sample and evaluated by two blinded graders coming to 
consensus for fluorescence staining uniformity and intensity 
with the following ordinal scale: 0 (no stain), 1 (moderate, 
non-uniform stain), 2 (moderate, uniform stain), 3 (intense 
stain) for each image. 
 Grades of immunohistochemical staining for GFAP and 
Iba1 were tested for evidence of differences between 1 and 4 
weeks time period for sham and NP-treated animals using 
Kruskal-Wallis one-way analysis of variance with a 0.05 
level of significance. When significance was observed, post-
hoc Wilcoxon Rank Sum Tests were conducted to detect 
differences in time for each group. 
Midbrain Immunostaining 
 At the time of sacrifice, midbrains from all animals were 
dissected en bloc and placed in optical cutting temperature 
(OCT) embedding media (Sakura Finetek) and frozen in 
liquid nitrogen until sectioning. Cryosections of midbrain 
(25μ m) were fixed in 4% formaldehyde (10 min, room 
temperature), permeabilized with 0.2% Triton (10 min), and 
incubated with blocking solution (30 min in 3.75% BSA and 
5% goat serum, Invitrogen). Sections were incubated with 
monoclonal mouse serotonin receptor 2b (5HT2b, 556334, 
BD Biosciences Pharmingen, San Jose, CA ) diluted 100x in 
blocking solution for 60 minutes. Samples were then washed 
with PBS and incubated with an AlexaFluor 488-conjugated 
secondary antibody (Molecular Probes) diluted 100x in 
blocking buffer for 30 minutes. Cell nuclei were 
counterstained using 0.5mg/ml propidium iodide (20 min, 
Sigma-Aldrich) and slides were mounted with GVA 
mounting solution (Invitrogen). 
 A separate protocol was used to immunolabel midbrain 
sections with antibodies against metabotropic glutamate and 
μ-opoid receptors as described here. Cryosections of 
midbrain (25 μm) were fixed in 10% formaldehyde (30 min, 
room temperature), quenched in peroxo-block (2 min, 1 part 
30% H2O2: 9 parts methanol), and incubated in ready-to-use 
2.5% normal horse blocking serum (20 min, ImmPRESS 
Universal Reagent kit: MP7500, Vector labs, Burlingame, 
CA). Samples were then incubated for 60 minutes with the 
following primary antibodies in blocking serum: rabbit 
polyclonal metabotropic glutamate receptor 5 (diluted 200x, 
mGluR5; ab53090, Abcam Inc, Cambridge, MA), rabbit 
polyclonal metabotropic glutamate receptor 4 (diluted 400x, 
mGluR4; 06-765, Upstate, Lake Placid, NY), or rabbit 
polyclonal μ-opioid receptor (diluted 100x, μ-OR, 44308G, 
Biosource, Camarillo CA). Samples were washed in PBS 
and incubated with ImmPRESS Peroxidase Universal anti 
mouse/rabbit Ig reagent (30 min, ImmPRESS Universal 
Reagent kit), washed again and incubated with 
diaminobenzideine-DAB solution (30 min, SK-4100, Vector 
labs). Cell nuclei were counterstained using Methyl Green 
(H-3402, Vector labs) for 5 minutes (600C) and mounted 
with GVA mounting solution (Invitrogen). 
 Immunostained sections of the rat midbrain were imaged 
with a confocal laser scanning microscope (5HT2b receptor 
only; Zeiss LSM 510, 20x objective; Zeiss, Jena, Germany) 
or a light microscope (Nikon Eclipse E600 POL, 4x 
objective; Nikon Instruments Inc, USA). Digital images 
were acquired of midbrain regions and analyzed as follows. 
For the 5HT2b receptor, images were thresholded on red and 
green channels to highlight labeled cell nuclei and associated 
staining. The numbers of cells and positively labeled cells 
were counted to determine the percent of positively stained 
cells. 
 To analyze intensity of positive staining for all other 
receptors, the periaqueductal gray (PAG) or red nucleus 
(RN) regions of the midbrain were first identified. Using 
Matlab, 526x526 pixel sized regions within the PAG or RN 
were obtained and converted to grayscale images. Images 
were then thresholded against a corresponding negative 
control to highlight only positively stained cells. After 
thresholding, images were converted to black and white 
images in order to calculate percent of positively stained 
pixels in Matlab. 
 Midbrain data (% positively labeled cells or % positively 
labeled pixels) for each pain receptor was analyzed for 
differences amongst pre-operative control, shamand NP-
treated groups at day 0, week 1 and week 4 time points by 
two-way analysis of variance (2-way ANOVA) at a 0.05 
level of significance. Tukey’s post-hoc analysis was 
performed when significance was observed. 
Cerebrospinal Fluid (CSF) Biomarker Assessment 
 Prior studiesdemonstrated elevated expression of 
monocyte-chemoattractant protein (MCP-1) in multiple 
sclerosis [28], acute spinal cord injury [29], and traumatic 
brain injury [30]. To investigate changes in CSF 
concentrations of MCP-1, CSF was collected at the time of 
sacrifice through a 23 gauge needle puncture of the 4
th
 
ventricle. Due to technical limitations, CSF samples were 
collected from 3 NP-treated rats at 1 week, 5 NP-treated rats 
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at 4 weeks, 6 sham rats at 1 week, and 4 sham rats at 4 
weeks. Levels of CSF MCP-1 were quantified using a 
commercially available ELISA (ERMCP-1C, Thermo Fisher 
Scientific, Waltham MA, USA) following the 
manufacturer’s instructions. Briefly, MCP-1 reference and 
rat CSF samples, diluted 1:25, were incubated in microwells 
coated with MCP-1 binding protein. Data were analyzed via 
an unbalanced two-factor, full-factorial ANOVA. 
RESULTS 
Mechanical Sensitivity 
 Mechanical allodynia was observed in the affected limb 
of animals exposed to autologous NP (Table 1). Lower 
values for 50% paw withdrawal thresholds among NP-
treated animals were observed when compared to pre-
operative testing, sham, and their own contralateral 
hindlimbs. This lower mechanical withdrawal threshold 
occurred early at 1 week and persisted through to the 4 week 
evaluation (p<0.05, Table 1). There was no evidence of a 
change in mechanical withdrawal thresholds in the affected 
limb of sham animals (p>0.05), nor was there evidence of a 
change in mechanical withdrawal thresholds in the 
contralateral limb for NP-treated or sham animals (data not 
shown). 
Weight Distribution 
 NP-treated animals had a weight-distribution imbalance 
at 1 week (p <0.05, Table 1), which was significantly 
different from the weight distribution observed pre-surgery 
(p<0.02, Table 1). By week 4, balanced weight-distribution 
returned in NP-treated animals. Weight-distribution in sham 
animals remained balanced and did not vary from pre-
surgery values. 
Temporal Gait Descriptors 
 NP-treated animals used imbalanced, asymmetric gaits at 
1 week (Table 1). Gait asymmetry and imbalance of limb 
duty factor was observed on the affected limb. Percentage 
stance times were significantly shorter on the affected limb 
relative to the contralateral limb (percentage stance time 
imbalance > 0%, p<0.05), and gait symmetry indicated that 
left and right foot-strikes were not equally spaced in time 
(gait symmetry  50%, p< 0.05). This temporal gait profile 
was significantly different from both pre-surgery values and 
sham controls at 1 week. By 4 weeks, NP-treated animals 
returned to balanced, symmetric gaits. Gait asymmetry and 
imbalance were not observed for sham animals. 
DRG Immunostaining 
 GFAP expression in the DRG was found to be higherin 
the DRGs of NP-treatedanimals at 4 weeks post-operatively 
as compared to the 1-week timepoint (p<0.0004) (Fig. 1), 
with no evidence of differences in GFAP staining for sham 
animals at either timepoint. Overall, the intensity of staining 
was found to be very low with mean values that correspond 
to moderate and non-uniform staining in the sham animals. 
 Very low levels of staining were observed in all DRGs 
for Iba1 expression, with no evidence of differences between 
1 and 4 week timepoints in either sham or NP-treated 
animals (Fig. 1). 
Midbrain Immunostaining 
 Expression of serotonin 2b receptor (5HT2b) was 
increased at 1 week in NP-treated animals (p<0.0015 vs 
unoperated controls) and returned to pre-operative control 
levels by 4 weeks (Fig. 2). Expression level of 5HT2b for 
sham animals remained the same level as pre-operative 
controls. Metabotropic glutamate receptor 5 expression 
(mGluR5) was increased in the PAG region of both sham 
(p<0.0001 vs pre-operative controls) and NP-treated animals 
(p<0.0001 vs pre-operative controls) at one week (Fig. 3). 
The increase in expression level of mGluR5 in the PAG at 
one week for NP-treated animals was significantly higher 
than sham animals (p<0.0001). By four weeks, mGluR5 
expression returned to the same expression level as pre-
operative controls in sham animals, while expression levels 
in NP-treated animals remained elevated (p<0.0001 vs pre-
operative controls and sham animals at 4 weeks). mGluR5 
expression levels in the RN of sham and NP-treated animals 
was not significantly different from each other and remained 
the same level as pre-operative controls (Fig. 3). mGluR4 
expression level of sham and NP-treated animals also 
remained the same as pre-operative controls at all time points 
(Fig. 4). Increased expression of μ-opioid receptor (μ-OR) 
was observed after 1 and 4 weeks in sham animals 
(p<0.0001 vs pre-operative controls) and NP-treated animals 
(p<0.0001 vs pre-operative controls) as compared to pre-
opreative control basal levels (Fig. 5). In NP-treated animals, 
expression levels of μ-opioid receptor increased even above 
sham animals levels at the 4 week timepoint (p<0.0001), but 
in PAG regions only. In the RN region, μ-opioid receptor 
Table 1. Data for Gait Parameters. All Data Shown are Mean ± Standard Error 
 
 Pre-Operative Sham (1 Week) Sham (4 Weeks) NP-Treated (1 Week) NP-Treated (4 Weeks) 
Mechanical withdrawal threshold 
(grams-force) 
14.6 ±1.2 7.4±1.1  11.8±2.1  3.4±0.7* 4.3±1.0*  
Weight-bearing 
(% weight on affected limb) 
49.5±1.0  47.3±3.0  50.0±0.7  41.9±3.1* 49.2±0.9  
Percentage stance time imbalance 
(% stance time, left-right limb) 
0.2±0.4  -0.6±0.9  0.0±0.6  4.1±1.4*# 1.5±1.7  
Gait symmetry 49.3±0.4  50.9±0.8  50.7±0.5  54.5±1.5* 52.0±2.3  
Imbalanced/asymmetric (p<0.05). 
*Different from pre-operative data (p<0.05). 
#Different from 1 week sham (p<0.05). 
Different from 4 week sham (p<0.05). 
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expression levels did not change for sham or NP-treated 
animals (Fig. 5). 
Cerebrospinal Fluid (CSF) Biomarker 
 MCP-1 was detectable in CSF of all rats in sham and NP-
treated groups at ng/ml levels (Fig. 6). When comparing 
MCP-1 levels between sham and NP-treated groups, MCP-1 
levels tended to be higher in NP treated rats as compared to 
sham-operated controls at the 4 week timepoint. The 
magnitude of difference in MCP-1 values was large between 
these two groups at 4 weeks post-operatively, nearly 2-fold, 
although a statistically significant difference was not 
 
Fig. (1). DRG Immunostaining: Glial fibrillary acidic protein (GFAP) in DRG (top; graphs A-B): Increased expression was observed in NP-
treated (*p<0.0004) animals at 4 weeks after surgery. Expression levels of GFAP in sham animals remained constant at all time points. 
Ionized calcium binding adaptor molecular 1 (Iba1) in DRG (bottom; graphs C-D): Expression level of Iba1 did not vary in sham or NP-
treated animals at any time point. 
 
Fig. (2). Serotonin 2b (5HT2b) Receptor Immunostaining: (left) Representative images of 5HT2b immunohistochemical images for sham (A) 
and NP-treated (B) 1 week after surgery (red=nuclei; green=positive staining; scale bar =100 μm). Increased expression was observed in NP-
treated (** p<0.015) animals at 1 week after surgery, but returned to pre-operative levels by 4 weeks post surgery. Expression level at 1 week 
for NP-treated animals was significantly different from sham animals (*p <0.015). Data are presented as mean ± standard deviation. 
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detected, likely due to large inter-animal variances and 
unequal sample numbers across groups (p=0.355, Fig. 6). 
DISCUSSION 
 Exposure of the dorsal root ganglion (DRG) to 
autologous nucleus pulposus (NP) has been well-studied as 
an animal model of radiculopathy through stab incision of 
the anulus fibrosus with consequent disc herniation [4], or 
through open placement of NP tissue upon the nerve root as 
performed here [13, 14]. Among these, a sustained 
sensitization of the DRG occurs as evidenced by elevated 
allodynia for the affected limb that is sustained for periods 
longer than 4 weeks [14]. This work similarly demonstrates 
mechanical allodynia in this model of radiculopathy, at both 
1 and 4 weeks after NP exposure, a persistence that is 
incongruous with short-term changes of altered stance 
symmetry and impaired gait at only 1 week after surgery 
with subsequent normalization thereafter. Findings for 
elevated astrocyte reactivity, but not microglial reactivity 
from histological examination of the affected DRG are 
interesting in light of prior reports for elevated astrocytic 
 
Fig. (3). Metabotropic Glutamate Receptor 5 (mGluR5) Immunostaining: PAG: (left) Representative images of mGluR5 
immunohistochemical images for sham (A) and NP-treated (B) 4 weeks after surgery (dark spots represent positive staining; scale bar =100 
μm). Increased expression was observed in both sham (*p<0.0001) and NP-treated (*p<0.0001) animals at 1 week after surgery compared to 
unoperated controls. At one week post surgery, mGluR5 expression levels was significantly different in NP-treated compared to sham 
(**p<0.0001). Expression levels of mGluR5 in sham animals returned to expression levels of pre-operative controls at 4 weeks while NP-
treated (**p<0.0001) animals continued to have increased expression of mGluR5. RN: Expression level of mGluR5 in the red nucleus did 
not vary in sham or NP-treated animals. Data are presented as mean ± standard deviation. 
 
Fig. (4). Metabotropic Glutamate Receptor 4 (mGluR4) Immunostaining: PAG: (left) Representative images of mGluR4 
immunohistochemical images for Sham (A) and NP-treated (B) 4 weeks after surgery (dark spots represent positive staining; scale bar = 100 
μm). Expression level of mGluR4 in the PAG did not vary in sham or NP-treated animals. RN: Expression level of mGluR4 in the RN did 
not vary in sham or NP-treated animals. Data are presented as mean ± standard deviation. 
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and/or microglial reactivity in the dorsal horn of the spinal 
cord after DRG injury due to compression or chemical 
exposure [9-11], and in the DRG region itself [14]. 
Numerous studies suggest that spinal astrocytic and 
microglial activation following nerve injury depend on the 
mechanism of injury, and are not predictive of sustained 
pain-related behaviors. It is likely that supraspinal 
descending modulation of the pain experience occurs in this 
scenario with no effect for brief stimuli such as Von Frey 
filament stimulation but significant effect for prolonged 
stimuli such as active gait. Studies of midbrain receptor 
expression revealed certain key receptors including high 
early serotonin receptor (5HT2B) expression at 1 week, 
persistent high metabotropic glutamate receptor (mGluR5) at 
1 and 4 weeks, and late and high expression of mu-opioid 
receptor (μ-OR) at 4 weeks. 
 The short-lived heightened 5HT2b expression in the 
ventral midbrain parallels findings for altered gait, where 
changes were observed at 1 week that returned to control 
levels by 4 weeks after surgery. Serotonin receptor 
modulation has been the subject of some study for mediating 
pain and nerve damage in lumbar radiculopathy [31], as well 
as for other incidences of nerve damage. Curiously, 5HT2b 
receptor polymorphisms have been associated in population 
studies with drug-seeking behavior, and also are found in 
humans to mediate the effects of amphetamines (MDMA). 
Following compression of the nerve root or cauda equina, 
serotonin has been found to constrict blood flow to the nerve 
root and to potentially contribute to sustained nerve injury 
[32, 33]. Administration of a specific serotonin receptor 
antagonist (5HT2) has been found to maintain blood flow 
levels and to eliminate the observed blood vessel diameter 
constriction. A pattern for increased serotonin receptor 
expression in the midbrain at short periods after injury may  
be consistent with a short-term nerve damage response, 
although additional studies would be required to determine if 
these central system changes could act to produce local 
changes in blood flow or other parameters at the site of nerve 
injury. Systemic delivery of serotonin 2 receptor antagonists 
have been shown to decrease allodynia [34] and have been 
used to treat pain and nociception in human subjects 
presenting with sciatica [32]. Based on prior studies showing 
that increased release of serotonin can occur in platelets and 
mast cells of injured or inflamed tissues that lead to 
hyperalgesic reactions in peripheral tissue [35], it is possible 
that an increased serotonin potentiation due to either elevated 
receptor expression or tissue injury contributes to the 
abnormal gait response observed in rats 1 week after surgery. 
 
Fig. (6). MCP-1 concentration in the CSF: At 1 Week, MCP-1 
concentration was comparable between NP-treated (n = 3) and 
sham animals (n = 6). By week 4, NP-treated animals (n = 5) 
tended to have higher levels of MCP-1 relative to sham (n = 4); 
however, this difference was non-significant (p = 0.355). Data are 
presented as mean ± standard error. 
 
Fig. (5). Mu-Opioid (μ-OR) Receptor Immunostaining: PAG: (left) Representative images of μ-OR immunohistochemical images for sham 
(A) and NP-treated (B) 4 weeks after surgery (dark spots represent positive staining; arrows indicate representative positive staining; scale 
bar = 100 μm). Increased expression was observed in both sham (*p<0.0001) and NP-treated (*p<0.0001) animals at 1 week after surgery. 
Expression levels of μ-OR in sham animals remained constant while expression levels of NP-treated animals continued to increase at 4 
weeks (**p<0.0001 vs 4 week sham animals). RN: Expression level of μ-OR in the RN did not vary in sham or NP-treated animals. Data are 
presented as mean ± standard deviation. 
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 Post surgery, increased expression levels ofmetabotropic 
glutamate receptor 5 (mGluR5)occurred early at 1 week and 
persisted for4 weeks in the ventral midbrain. This pattern is 
consistent with the known roles of both the PAG and the dorsal 
midbrain raphe nuclei in pain perception and sensory function. 
A prior study reported an ability for mGluR5 antagonists to 
reduce allodynia and hyperalgesia following spinal nerve 
ligation [36-38] further confirming a role for this receptor in 
mediating sensitivity. In addition, animal models of neuropathic 
pain have demonstrated an increase in glutamatergic input from 
primary afferents to spinal dorsal horn neurons after injury, 
resulting in increased excitation of mGluR receptors [39, 40]. 
The observed increase in mGluR5 receptor expression levels 
provides evidence of potential supraspinal altered glutamatergic 
transmission in the setting of peripheral nerve injury. 
Importantly, the contradistinction with early increased mGluR5 
levels in the sham animals, and subsequent reversal to control 
levels at 4 weeks after surgery, clearly demonstrates that 
placement of NP tissue on the DRG is related to a differential 
and sustained effect that differs from that due to surgery alone. 
 Activation of the mu-opioid receptor at the level of the 
midbrain PAG is known to decrease afferent noxious 
transmission by decreasing dorsal horn neuron firing, 
decreasing nociceptive transmission through a physiology 
involving decreased potassium conductance. Stimulation of this 
region in animal models of acute pain has been demonstrated to 
alleviate allodynia and provide for phenotypic normalization, 
however no long-term studies have been performed to observe 
alteration of system sensitivity by changed receptor expression 
levels. All changes in the expression of the μ-opioid receptor 
following sham surgery or NP-treatment were noted in the 
ventral midbrain, likely primarily in the PAG, consistent with 
their anatomic localization to this region. In prior studies of 
nerve ligation, μ-OR expression has decreased (rather than 
increased) in the spinal cord following injury [41], while studies 
of chronic constriction nerve injury present findings for an 
increase in μ-OR in the spinal dorsal horn [42]. These 
observations suggest that μ-OR reactions depend on the 
mechanism of injury and more specifically on the integrity of 
the primary sensory neuron. Our findings of elevated μ-OR 
expression in the midbrains of both sham surgery and NP-
treated animals at 1 week after surgery provide further evidence 
that μ-OR remodeling may be a broader response to local injury, 
but that the sustained and elevated expression of μ-OR in NP-
treated animals at the 4 week timepoint may represent an 
adaptive response to how the animals overcome sustained 
allodynia to provide for normalization of gait. 
 A new finding here is the trend for elevated monocyte 
chemoattractant protein (MCP-1) in cerebrospinal fluid of NP-
treated rats at 4 weeks after surgery. MCP-1 recruits monocytes 
to sites of injury and infection, and is elevated in the CSF of 
patients with significant spinal cord injury [43, 44]. These 
studies provide evidence that cord injury can be associated with 
modified profiles in the CSF for MCP-1 in addition to a number 
of other chemokines reported previously including interleukins-
8 and -6. Nevertheless, epidural lavage fluids obtained from 
patients with disc herniation demonstrated no measurable 
differences in MCP-1 levels, or numerous other chemokines 
and cytokines, between fluids from normal volunteer subjects 
and affected patients [45]. While there is great interest in 
identifying a biomarker of radiculopathy-associated pathology, 
these results for MCP-1 are insufficient to suggest its utility as a 
measured biomarker for use in human subjects. 
CONCLUSION 
 In summary, the results of this study identify sustained 
mechanical allodynia, yet transient changes in stance symmetry 
and gait, for rats following NP placement upon the lumbar DRG 
as a model of radiculopathy. Activated microglia at the DRG 
was also observed in rats of the radiculopathy model. 
Evaluation of changes in neurotransmitter receptors at the 
midbrain PAG suggests an adaptive response to radiculopathy 
that may alter sensitivity to endogenous activation. High levels 
of metabotropic glutamate receptor 5 persist over the course of 
the study while only at late time points does μ-opioid receptor 
show increased expression in the PAG region of the midbrain. 
Additional studies would be helpful to reveal the kinetics of 
midbrain receptor expression for a broader and more 
comprehensive panel of receptors following induction of 
radiculopathy using this rat model. These results are important 
for demonstrating that local injury at the DRG is associated with 
central remodeling at the midbrain, and points towards potential 
targets for therapeutic interventions for the treatment of 
radiculopathy. 
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